Symphysis Medical

Independence | Comfort | Quality of Life

Developing an innovative drainage technology to treat malignant pleural effusions (MPE)

Read more...
Better Outcomes

Better
Outcomes

 

Incorporates an active component that will significantly shorten the treatment duration of MPE compared to current catheter devices.

 

Patient Centric

Patient
Centric

A user-friendly design to promote patient independence, comfort and quality of life.


Cost Effective

Healthcare
Savings

Reduces the costs associated with long-term home drainage and acute readmissions to hospital.


SymPhysis Medical

Located in gALWAY, IRELAND

 

linked to experts internationally

 

SymPhysis Medical wins the MedTech Innov…

Posted in News by Mary Faherty

4th May, 2022

SymPhysis Medical were thrilled to win the MedTech Innovator Dublin International Pitch event, which took place in Dublin on 25 & 26 April 2022. MedTech Innovator is a global competition and...

Read more

SymPhysis Medical shortlisted in the HIH…

Posted in News by Symphysis Medical

28th February, 2022

SymPhysis Medical is delighted to be included in the Health Innovation Hub Ireland (HIHI) 20 Health Innovations to watch for 2022. The Innovation Showcase was launched by Taoiseach Mr Micheál Martin...

Read more

Disruptive Technology to Improve Palliat…

Posted in News by Mary Faherty

12th January, 2022

An exciting new collaboration is underway in the West of Ireland, bringing disruptive technology into the palliative care space. A consortium of four organisations have joined forces to bring to market...

Read more
Hannah Booker, Innovation Associate at NICA, logging data during SymPhysis Medical’s prototype testing

Testing Symphysis Medical's Product at t…

Posted in News by Symphysis Medical

4th January, 2022

The SymPhysis Medical team has been working with the National Innovation Centre for Ageing (NICA) at their hub of innovation, The Catalyst, in Newcastle-Upon-Tyne in the UK. In December, the...

Read more

MPE By Numbers

Mesothelioma

Affects ~90% of patients with mesothelioma.

Lung Cancer

Affects ~ 35% of patients with lung cancer.

Breast Cancer

Affects ~ 16% of patients with breast cancer.

Lymphoma

Affects ~ 11% of patients with lymphoma.